These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 30543136)
1. Enhanced combination cancer therapy using lipid-calcium carbonate/phosphate nanoparticles as a targeted delivery platform. Wu Y; Gu W; Xu ZP Nanomedicine (Lond); 2019 Jan; 14(1):77-92. PubMed ID: 30543136 [TBL] [Abstract][Full Text] [Related]
2. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity. Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661 [No Abstract] [Full Text] [Related]
3. Designed Synthesis of Lipid-Coated Polyacrylic Acid/Calcium Phosphate Nanoparticles as Dual pH-Responsive Drug-Delivery Vehicles for Cancer Chemotherapy. Wang X; Zhang M; Zhang L; Li L; Li S; Wang C; Su Z; Yuan Y; Pan W Chemistry; 2017 May; 23(27):6586-6595. PubMed ID: 28218434 [TBL] [Abstract][Full Text] [Related]
4. Multifunctional lipid-coated calcium phosphate nanoplatforms for complete inhibition of large triple negative breast cancer via targeted combined therapy. Tang J; Li B; Howard CB; Mahler SM; Thurecht KJ; Wu Y; Huang L; Xu ZP Biomaterials; 2019 Sep; 216():119232. PubMed ID: 31195300 [TBL] [Abstract][Full Text] [Related]
5. Targeted co-delivery of protein and drug to a tumor in vivo by sophisticated RGD-modified lipid-calcium carbonate nanoparticles. Peng JQ; Fumoto S; Suga T; Miyamoto H; Kuroda N; Kawakami S; Nishida K J Control Release; 2019 May; 302():42-53. PubMed ID: 30926479 [TBL] [Abstract][Full Text] [Related]
6. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy. Li TS; Yawata T; Honke K Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005 [TBL] [Abstract][Full Text] [Related]
7. A dual-targeting strategy for enhanced drug delivery and synergistic therapy based on thermosensitive nanoparticles. Wang M; You C; Gao Z; Wu H; Sun B; Zhu X; Chen R J Biomater Sci Polym Ed; 2018 Aug; 29(11):1360-1374. PubMed ID: 29611463 [TBL] [Abstract][Full Text] [Related]
8. Facile preparation of heparin/CaCO3/CaP hybrid nano-carriers with controllable size for anticancer drug delivery. Liang P; Zhao D; Wang CQ; Zong JY; Zhuo RX; Cheng SX Colloids Surf B Biointerfaces; 2013 Feb; 102():783-8. PubMed ID: 23104038 [TBL] [Abstract][Full Text] [Related]
9. Enhanced delivery of siRNA to triple negative breast cancer cells in vitro and in vivo through functionalizing lipid-coated calcium phosphate nanoparticles with dual target ligands. Tang J; Howard CB; Mahler SM; Thurecht KJ; Huang L; Xu ZP Nanoscale; 2018 Mar; 10(9):4258-4266. PubMed ID: 29436549 [TBL] [Abstract][Full Text] [Related]
11. Silencing PD-1 and PD-L1 with nanoparticle-delivered small interfering RNA increases cytotoxicity of tumor-infiltrating lymphocytes. Wu Y; Gu W; Li J; Chen C; Xu ZP Nanomedicine (Lond); 2019 Apr; 14(8):955-967. PubMed ID: 30901292 [TBL] [Abstract][Full Text] [Related]
12. Combination of NF-kB targeted siRNA and methotrexate in a hybrid nanocarrier towards the effective treatment in rheumatoid arthritis. Duan W; Li H J Nanobiotechnology; 2018 Jul; 16(1):58. PubMed ID: 30060740 [TBL] [Abstract][Full Text] [Related]
13. Application of a lipid-coated hollow calcium phosphate nanoparticle in synergistic co-delivery of doxorubicin and paclitaxel for the treatment of human lung cancer A549 cells. Wu C; Xu J; Hao Y; Zhao Y; Qiu Y; Jiang J; Yu T; Ji P; Liu Y Int J Nanomedicine; 2017; 12():7979-7992. PubMed ID: 29184399 [TBL] [Abstract][Full Text] [Related]
14. Lipid-coated nano-calcium-phosphate (LNCP) for gene delivery. Zhou C; Yu B; Yang X; Huo T; Lee LJ; Barth RF; Lee RJ Int J Pharm; 2010 Jun; 392(1-2):201-8. PubMed ID: 20214964 [TBL] [Abstract][Full Text] [Related]
15. Modification of nanostructured calcium carbonate for efficient gene delivery. Zhao D; Wang CQ; Zhuo RX; Cheng SX Colloids Surf B Biointerfaces; 2014 Jun; 118():111-6. PubMed ID: 24732398 [TBL] [Abstract][Full Text] [Related]
16. Smart aptamer-modified calcium carbonate nanoparticles for controlled release and targeted delivery of epirubicin and melittin into cancer cells in vitro and in vivo. Yazdian-Robati R; Arab A; Ramezani M; Rafatpanah H; Bahreyni A; Nabavinia MS; Abnous K; Taghdisi SM Drug Dev Ind Pharm; 2019 Apr; 45(4):603-610. PubMed ID: 30633594 [TBL] [Abstract][Full Text] [Related]
17. Osteogenic Evaluation of Porous Calcium Phosphate Granules with Drug Delivery System Using Nanoparticle Carriers. Son JS; Kwon TY; Kim KH J Nanosci Nanotechnol; 2015 Jan; 15(1):130-3. PubMed ID: 26328316 [TBL] [Abstract][Full Text] [Related]
18. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo. He XW; Liu T; Chen YX; Cheng DJ; Li XR; Xiao Y; Feng YL Cancer Gene Ther; 2008 Mar; 15(3):193-202. PubMed ID: 18202713 [TBL] [Abstract][Full Text] [Related]
19. Combination of paclitaxel- and retinoic acid-incorporated nanoparticles for the treatment of CT-26 colon carcinoma. Hong GY; Jeong YI; Lee SJ; Lee E; Oh JS; Lee HC Arch Pharm Res; 2011 Mar; 34(3):407-17. PubMed ID: 21547672 [TBL] [Abstract][Full Text] [Related]
20. Layer-by-layer nanoparticle platform for cancer active targeting. Suh MS; Shen J; Kuhn LT; Burgess DJ Int J Pharm; 2017 Jan; 517(1-2):58-66. PubMed ID: 27923697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]